Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00939471 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Balloon Sinuplasty in Pediatric Sinusitis
A NA study of Chronic Sinusitis, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT00939471: Completed NA study of Chronic Sinusitis, sponsored by Integra LifeSciences Corporation.
NCT00939471 is a NA study of Chronic Sinusitis that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 44 participants, below the 191-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00939471, a NA study of Chronic Sinusitis, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
A non-randomized, multi-center, prospective, clinical study intended to evaluate the safety and efficacy of balloon sinuplasty devices in pediatric patients with longstanding sinusitis following failed medical management.
Primary Outcome
Number of device-related adverse events from time of procedure through 12 months post-procedure.
Conditions Studied
Interventions
- DEVICE Relieva™ Balloon Sinuplasty™ System
Study Locations (1)
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2007-04-01 |
| Est. Completion | 2010-05-01 |
| Phase | NA |
What the finished NCT00939471 record still lists
NCT00939471 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 191-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Chronic Sinusitis appearing as the primary indexed condition, and to 1 intervention - of which Relieva™ Balloon Sinuplasty™ System is the first listed.
NCT00939471 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT00939471 about?
NCT00939471 is a clinical study titled "Safety and Efficacy of Balloon Sinuplasty in Pediatric Sinusitis". A non-randomized, multi-center, prospective, clinical study intended to evaluate the safety and efficacy of balloon sinuplasty devices in pediatric patients with longstanding sinusitis following failed medical management.
What is the current status of trial NCT00939471?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2007-04-01. Estimated completion is 2010-05-01.
What conditions does trial NCT00939471 study?
This clinical trial studies the following conditions: Chronic Sinusitis.
What interventions are being tested in trial NCT00939471?
The interventions under investigation include: Relieva™ Balloon Sinuplasty™ System (DEVICE).
Who is sponsoring clinical trial NCT00939471?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00939471 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Sinusitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00939471's enrollment target sits among peer trials
44 5th of 9 higher than 5 of 9 other Chronic Sinusitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Sinusitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Evaluation of Maxillary Antrostomy Versus Ostial Dilation Efficacy Through Long-Term Follow-Up
COMPLETED · NA
-
The PIO (Propel In Office) III Study of In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery
COMPLETED · NA
-
Intraoperative and Post-operative Analgesic Effect of IV Acetaminophen for Sinus Surgery
COMPLETED · NA
-
XprESS Maxillary Balloon Dilation Study
COMPLETED · NA
-
Genetic Factors in Chronic Sinusitis
ACTIVE NOT RECRUITING
-
Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI